Impact of contrast-enhanced ultrasonography in a tertiary clinical practice

Journal of Ultrasound in Medicine

Volumn 26, Issue 12, 2007, Pages 1703-1714

  Lanka, Bina ^a,c   Jang, Hyun Jung ^a   Tae, Kyoung Kim ^a   Burns, Peter N ^a,b   Wilson, Stephanie R ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c WAIKATO HOSPITAL   (New Zealand)

^d FOOTHILLS HOSPITAL   (Canada)

Author keywords

Liver neoplasms; Microbubbles; Ultrasonography; Ultrasound contrast agents

Indexed keywords

CHARACTERIZATION; COMPUTERIZED TOMOGRAPHY; HISTOLOGY; MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; TUMORS; ULTRASONOGRAPHY;

CLINICAL PRACTICE; LIVER NEOPLASMS; MICROBUBBLES; ULTRASOUND CONTRAST AGENTS;

ONCOLOGY;

IODINATED CONTRAST MEDIUM; PERFLUTREN;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE SURVEILLANCE; ECHOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; TERTIARY HEALTH CARE;

EID: 36749009005     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.12.1703     Document Type: Article

References (25)

1. Hohmann J, Albrecht T, Hoffmann CW, Wolf KJ. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol 2003; 46:147-159.
2. Quaia E, Stacul F, Gaiani S, et al. Comparison of diagnostic performance of unenhanced vs SonoVue-enhanced ultrasonography in focal liver lesions characterization: the experience of three Italian centers. Radiol Med (Torino) 2004; 108:71-81.
3. Bleuzen A, Tranquart F. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 2004; 14(suppl 8):P53-P62.
4. Nicolau C, Vilana R, Bru C. The use of contrast-enhanced ultrasound in the management of the cirrhotic patient and for detection of HCC. Eur Radiol 2004; 14(suppl 8):P63-P71.
5. Nicolau C, Vilana R, Catala V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 2006; 186:158-167.
6. Albrecht T, Blomley MJ, Burns PN, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227:361-370.
7. Kim TK, Choi BI, Hong HS, Choi BY, Han JK. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SH U 508A: preliminary study. Ultrasound Med Biol 2000; 26:1439-1444.
8. Solbiati L, Tonolini M, Cova L. Monitoring RF ablation. Eur Radiol 2004; 14(suppl 8):P34-P42.
9. Dill-Macky MJ, Asch M, Burns P, Wilson S. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR Am J Roentgenol 2006; 186(suppl):S287-S95.
10. Thorelius L. Contrast-enhanced ultrasound for extrahepatic lesions: preliminary experience. Eur J Radiol 2004; 51(suppl):S31-S38.
11. Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 2006; 186:1401-1412.
12. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232:420-430.
13. Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol 2006; 186:1551-1559.
14. Greenbaum L, Burns P, Copel J, et al. American Institute of Ultrasound in Medicine recommendations for contrast-enhanced liver ultrasound imaging clinical trials. J Ultrasound Med 2007; 26:705-716.
15. Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-MI contrast-enhanced ultrasound. AJR Am J Roentgenol 2007. In press.
16. Murphy-Lavallee J, Jang HJ, Kim TK, Burns PN, Wilson SR. Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography. J Ultrasound Med 2007; 26:1545-1556.
17. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma on contrast-enhanced ultrasound: correlation with pathologic differentiation. Radiology 2007; 244:898-906.
18. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
19. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images - concordance of US scans with CT scans and MR images. Radiology 2007; 242:162-174.
20. Passamonti M, Vercelli A, Azzaretti A, Rodolico G, Calliada F. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT. Radiol Med (Torino) 2005; 109:358-369.
21. Kim TK, Jang HJ, Wilson SR. Benign liver masses: imaging with microbubble contrast agents. Ultrasound Q 2006; 22:31-39.
22. Jang HJ, Kim TK, Wilson SR. Imaging of malignant liver masses: characterization and detection. Ultrasound Q 2006; 22:19-29.
23. Wink MH, Wijkstra H, De La Rosette JJ, Grimbergen CA. Ultrasound imaging and contrast agents: a safe alternative to MRI? Minim Invasive Ther Allied Technol 2006; 15:93-100.
24. Leen E, Moug SJ, Horgan P. Potential impact and utilization of ultrasound contrast media. Eur Radiol 2004; 14(suppl 8):P16-P24.
25. Lencioni R. Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol 2006; 16:1610-1613.